Morning Breakouts

Latest California Healthline Stories

Urgent Care Clinic Proposed for Site of Former San Jose Medical Center

San Jose city and county officials are considering acquiring the site of the former San Jose Medical Center to open an urgent care clinic in an effort to restore some health services downtown residents lost when SJMC closed in December 2004, the San Jose Mercury News reports.

State Fines Kaiser Permanente for Privacy Breach

The Department of Managed Health Care on Monday announced that it had issued a $200,000 fine against a division of Oakland-based Kaiser Permanente for storing personal patient information on a publicly accessible Web site, the Los Angeles Times reports.

Bush Promotes New Medicare Prescription Drug Benefit in Minnesota

President Bush on Friday launched his “grassroots effort to educate people” about the new Medicare prescription drug benefit at an invitation-only event for about 400 people in Maple Grove, Minn., the St. Paul Pioneer Press reports.

Schwarzenegger Accepted Contributions From Cited Nursing Home Operator

Gov. Arnold Schwarzenegger (R) has accepted a total of $67,300 in campaign contributions from Emmanuel Bernabe, a nursing home operator who has been fined $285,000 by state regulators since Schwarzenegger became governor, according to campaign finance reports, the Los Angeles Times reports.

DOJ, Industry Attorneys To Meet With Kessler To Discuss Tobacco Trial

U.S. District Judge Gladys Kessler, who is presiding over the federal government’s civil racketeering lawsuit against several U.S. tobacco companies, is scheduled to meet with government and tobacco lawyers on Monday to discuss the Department of Justice’s proposed penalties against the industry and the status of the case, the Washington Post reports.

AMA Weighs Support for Moratorium on Direct-To-Consumer Drug Advertising

The American Medical Association during its annual meeting in Chicago on Sunday weighed whether to support proposed federal legislation that would impose a moratorium to delay direct-to-consumer drug advertising after drugs are approved by FDA, the Chicago Tribune reports.